• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Impact of coronavirus disease 2019 on time delay and functional outcome of mechanical thrombectomy in Tokyo, Japan
Several papers from around the world have reported that outbreaks of coronavirus disease 2019 (COVID-19) have led to the following time delays associated with endovascular mechanical thrombectomy (MT) for patients with acute ischemic stroke (AIS): onset-to-door (O2D) time,1,2 door-to-puncture (D2P) time and door-to-recanalization time.3 Several speculative factors may explain these delays, such as a collapse of emergency services focused on patients with COVID-192 and patients ’ fear of exposure to COVID-19 through interactions within the health-care system.
Source: Journal of Stroke and Cerebrovascular Diseases - August 12, 2021 Category: Neurology Authors: Masahiro Katsumata, Takahiro Ota, Junya Kaneko, Hiroyuki Jimbo, Rie Aoki, Shigeta Fujitani, Masahiko Ichijo, Masato Inoue, Keigo Shigeta, Yoshifumi Miyauchi, Yu Sakai, Hideki Arakawa, Yoshinobu Otsuka, Kenichi Ariyada, Yoshiaki Kuroshima, Takahisa Fuse, Y Source Type: research

Patent Foramen Ovale related cryptogenic stroke during COVID-19 disease in three patients: a case series
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), termed COVID-19, first detected in Whuan, was officially declared a pandemic by the World Health Organization on March 11, 2020. The epidemic of COVID-19 has rapidly spread worldwide. Italy was the first European country to be affected and, currently, Italy has reported 4,343,397 COVID-19-positive cases (1).
Source: Journal of Stroke and Cerebrovascular Diseases - September 13, 2021 Category: Neurology Authors: Daniela Palleri, Marta Guidarini, Elisabetta Mariucci, Anna Balducci, Gabriele Egidy Assenza, Susanna Esposito, Andrea Donti Source Type: research

Treatment of ChAdOx1 nCoV-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia Related Acute Ischemic Stroke
We report clinical, laboratory, imaging findings and treatment in a 51-year-old female presenting with acute left middle cerebral artery (MCA) occlusion 7 days after the first dose of ChAdOx1 nCoV-19 vaccine.
Source: Journal of Stroke and Cerebrovascular Diseases - August 28, 2021 Category: Neurology Authors: Jana Kenda, Dimitrij Lovri č, Matevž Škerget, Nataša Milivojević Tags: Short Communication Source Type: research

Shortening Door-to-Needle Time by Multidisciplinary Collaboration and Workflow Optimization During the COVID-19 Pandemic
This study aims to evaluate shortening door-to-needle time of intravenous recombinant tissue plasminogen activator of acute ischemic stroke patients by multidisciplinary collaboration and workflow optimization based on our hospital resources.Materials and Methods: We included patients undergoing thrombolysis with intravenous recombinant tissue plasminogen activator from January 1, 2018, to September 30, 2020. Patients were divided into pre- (January 1, 2018, to December 31, 2019) and post-intervention groups (January 1, 2020, to September 31, 2020).
Source: Journal of Stroke and Cerebrovascular Diseases - October 19, 2021 Category: Neurology Authors: Yimin Chen, Thanh N Nguyen, Jack Wellington, Mohammad Mofatteh, Weiping Yao, Zhaohui Hu, Qiuping Kuang, Weijuan Wu, Xuejun Wang, Yu Sun, Kexun Ouyang, Junmiao Xu, Weiquan Huang, Shuiquan Yang Source Type: research

Variation in Patterns of Telestroke Usage during the COVID-19 Pandemic
Early in the pandemic there was a substantial increase in telestroke uptake among hospitals. The motivations for using telestroke during the pandemic might be different than hospitals that adopted telestroke previously. We compared stroke care among hospitals that adopted telestroke prior to the pandemic to hospitals that adopted telestroke during the pandemic.
Source: Journal of Stroke and Cerebrovascular Diseases - February 5, 2023 Category: Neurology Authors: Carter H. Nakamoto, Andrew D. Wilcock, Lee H Schwamm, Kori S Zachrison, Lori Uscher-Pines, Ateev Mehrotra Source Type: research

The Impact of a Two-Year Long COVID-19 Public Health Restriction Program on Mechanical Thrombectomy Outcomes in a Stroke Network
The purpose of this study was to evaluate the impact of COVID-19 pandemic public health restrictions on our drip and ship mechanical thrombectomy program in Santiago Chile.
Source: Journal of Stroke and Cerebrovascular Diseases - April 17, 2023 Category: Neurology Authors: Rodrigo Rivera Source Type: research

Mortality Following Mechanical Thrombectomy for Ischemic Stroke in Patients with COVID-19
Multiple prior studies have shown a relationship between COVID-19 and strokes; further, COVID-19 has been shown to influence both time-to-thrombectomy and overall thrombectomy rates. Using large-scale, recently released national data, we assessed the association between COVID-19 diagnosis and patient outcomes following mechanical thrombectomy.
Source: Journal of Stroke and Cerebrovascular Diseases - May 4, 2023 Category: Neurology Authors: Jonathan Dallas, Talia A. Wenger, Kristie Q. Liu, Li Ding, Benjamin S. Hopkins, Frank J. Attenello, William J. Mack Source Type: research

Neurological Issues in COVID-19, Summarized in Verse
In pandemic COVID-19,
Source: Journal of Stroke and Cerebrovascular Diseases - May 9, 2020 Category: Neurology Authors: Meredith R. Golomb Tags: Special section, letter to the editor, consider for rapid communication Source Type: research

Impact of Cerebrovascular and Cardiovascular Diseases on Mortality and Severity of COVID-19 – Systematic Review, Meta-analysis, and Meta-regression
At the time of writing this paper, Coronavirus Disease 2019 (COVID-19) was announced as a global pandemic which has infected over 3.3 million people and cause more than 238.000 deaths,1 these numbers are likely to increase by the time of publication. Even though most of the infected individuals have mild or no symptoms, some of them exhibit more serious complications, including severe pneumonia, acute respiratory distress syndrome, and multi-organ failure. Clinical markers can be valuable for efficient allocation of resources during a pandemic.
Source: Journal of Stroke and Cerebrovascular Diseases - May 13, 2020 Category: Neurology Authors: Raymond Pranata, Ian Huang, Michael Anthonius Lim, Prof. Eka Julianta Wahjoepramono, Julius July Source Type: research

Cerebral Venous Thrombosis: Atypical Presentation of COVID-19 in the Young
Identify clinical and radiographic features of venous infarct as a presenting feature of COVID-19 in the young.
Source: Journal of Stroke and Cerebrovascular Diseases - May 22, 2020 Category: Neurology Authors: David E. Klein, Richard Libman, Claudia Kirsch, Rohan Arora Tags: Case Report Source Type: research

Subarachnoid hemorrhage guidance in the era of the COVID-19 pandemic -An opinion to mitigate exposure and conserve personal protective equipment
Aneurysmal subarachnoid hemorrhage (SAH) patients require frequent neurological examinations, neuroradiographic diagnostic testing and lengthy intensive care unit stay. Previously established SAH treatment protocols are impractical to impossible to adhere to in the current COVID-19 crisis due to the need for infection containment and shortage of critical care resources, including personal protective equipment (PPE). Centers need to adopt modified protocols to optimize SAH care and outcomes during this crisis.
Source: Journal of Stroke and Cerebrovascular Diseases - June 4, 2020 Category: Neurology Authors: Thanh N. Nguyen, Ashutosh P. Jadhav, Hormuzdiyar H. Dasenbrock, Raul G. Nogueira, Mohamad Abdalkader, Alice Ma, Anna M. Cervantes-Arslanian, David M. Greer, Ali Daneshmand, Dileep R. Yavagal, Tudor G. Jovin, Osama O. Zaidat, Sherry Hsiang-Yi Chou Tags: Review Article Source Type: research

COVID-19 pandemic and burden of non-communicable diseases: An ecological study on data of 185 countries
Preventive measures against COVID-19 should protect the public from the dual burden of communicable and non-communicable diseases, particularly in the elderly. In addition to active COVID-19 surveillance, policymakers should utilize this evidence as a guide for prevention and coordination of health services. This model is timely, as many countries have begun to reduce social isolation.
Source: Journal of Stroke and Cerebrovascular Diseases - June 24, 2020 Category: Neurology Authors: M. Reza Azarpazhooh, Negar Morovatdar, Abolfazl Avan, Thanh G Phan, Afshin A. Divani, Nawaf Yassi, Saverio Stranges, Brian Silver, Jos é Biller, Masoud Tokazebani Belasi, Sepideh Kazemi Neya, Bita Khorram, Asher Frydman, Yongchai Nilanont, Elisa Onorati, Source Type: research

Bilateral posterior infarction in a SARS-Cov-2 infected patient: discussion about an unusual case
We present a case of bilateral occipito-temporal infarction revealed by a sudden cortical blindness with haemorrhagic transformation after intravenous thrombolysis in a diabetic patient infected by Covid-19. Differential diagnoses are discussed in front of this unusual presentation and evolution.
Source: Journal of Stroke and Cerebrovascular Diseases - June 27, 2020 Category: Neurology Authors: Claire Bonardel, Mathieu Bonnerot, Marie Ludwig, Wilfried Vadot, Gaspard Beaune, Bruno Chanzy, Lucie Cornut, H élène Baysson, Magali Farines, Isabelle Combes, Gabriel Macheda, Fabrice Bing Tags: Case Report Source Type: research

The interplay between COVID 19 and non-communicable diseases
Since the coronavirus designated as COVID-19 emerged as a global pathogen in late 2019, there has been rapid spread across the globe. After originating in China, several high-income countries such as Italy, Spain, United States, and the United Kingdom have had high case prevalence and high levels of mortality.
Source: Journal of Stroke and Cerebrovascular Diseases - June 30, 2020 Category: Neurology Authors: Seemant Chaturvedi, Philip Gorelick Source Type: research

In defense of our patients: indirect negative neurological consequences of sars-cov-2 in the new york epicenter
New York has become the epicenter in the United States for the coronavirus disease 2019 (COVID-19) pandemic with approximately 202,829 infected, 52,697 hospitalized, and 17,055 confirmed deaths as of June 5, 2020.15 The large influx of critically ill patients resulted in widespread policy and practice changes to counter this new resource-limited setting. All elective surgeries were cancelled. Urgent cases required approval and were limited significantly, resulting in primarily emergency cases.
Source: Journal of Stroke and Cerebrovascular Diseases - July 9, 2020 Category: Neurology Authors: Jared B. Cooper, Anubhav G. Amin, Michael G. Kim, Alan A. Stein, Jose Dominguez, Krishna Amuluru, Rachana Tyagi, Stephan Mayer, Chirag D. Gandhi, Fawaz Al-Mufti Source Type: research

Pages: 1  2  3  4  5  6  7  8  9  10  11  12  13